Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qi Yan
Institution:
Chengdu Medical College
Observed institutions:
Anhui Medical University,
Nankai University,
Chengdu Medical College,
State Key Laboratory of Medicinal Chemical Biology
ORCID:
0000-0002-6535-4358
Observed ORCID:
0000-0002-6535-4358
OpenAlex ID:
A5017402636
PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism
2022
·
Mingming Sun
, Leilei Li
, et al.
·
Acta Pharmaceutica Sinica B
·
86
PDF
Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment
2022
·
Tianyu Chen
, Hui Chen
, et al.
·
Pharmaceuticals
·
37
Co-encapsulation of paclitaxel and 5-fluorouracil in folic acid-modified, lipid-encapsulated hollow mesoporous silica nanoparticles for synergistic breast cancer treatment
2022
·
Huanli Yin
, Qi Yan
, et al.
·
RSC Advances
·
28
PDF
Research progress on the role of cholesterol in hepatocellular carcinoma
2022
·
Li Peng
, Qi Yan
, et al.
·
European Journal of Pharmacology
·
16
Malate, a natural inhibitor of 6PGD, improves the efficacy of chemotherapy in lung cancer
2024
·
Mingming Sun
, Qi Feng
, et al.
·
Lung Cancer
·
9
The non-metabolic function of 6PGD coordinates CCNA2 and HMGA2 expression to drive colorectal cancer progression and drug response
2025
·
Mingming Sun
, Qi Yan
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
3
Targeting of Mitochondria in Triple-Negative Breast Cancer Cells Using Berberine Derivative Self-Assembled Micelles Coated with Erythrocyte-Cancer Hybrid Membranes
2026
·
Qi Yan
, Shiyu Wang
, et al.
·
BioNanoScience
Show more works
View as search
Works count:
7
Citation count:
179
H-index:
5
I10-index:
4
Year
Topic
Type